Value of routine test for identifying colorectal cancer from patients with nonalcoholic fatty liver disease

被引:4
作者
Yang, Rong [1 ]
Chen, Yu [2 ]
Chen, Xianlai [3 ,4 ]
机构
[1] Cent South Univ, Xiangya Hosp, Changsha 410078, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China
[3] Cent South Univ, Inst Informat Secur & Big Data, 932 South Lushan Rd, Changsha 410083, Hunan, Peoples R China
[4] Cent South Univ, Natl Engn Lab Med Big Data Applicat Technol, Changsha 410083, Hunan, Peoples R China
基金
国家重点研发计划;
关键词
Nonalcoholic fatty liver disease; Colorectal neoplasms; Diagnostic tests; routine; Early detection of Cancer; RISK; ASSOCIATION; SERUM;
D O I
10.1186/s12876-020-01327-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Nonalcoholic fatty liver disease (NAFLD) is a risk factor for colorectal neoplasms. Our goal is to explore the relationship between NAFLD and colorectal cancer (CRC) and to analyze potential indicators for screening CRC in NAFLD based on clinical big data. Methods Demographic information and routine clinical indicators were extracted from Xiangya Medical Big Data Platform. 35,610 NAFLD cases without CRC (as group NAFLD-CRC), 306 NAFLD cases with CRC (as group NAFLD-NonCRC) and 10,477 CRC cases without NAFLD were selected and evaluated. The CRC incidence was compared between NAFLD population and general population by Chi-square test. Independent sample t-test was used to find differences of age, gender and routine clinical indicators in pairwise comparisons of NAFLD-CRC, NAFLD-NonCRC and nonNAFLD-CRC. Results NAFLD population had a higher CRC incidence than general population (7.779 parts per thousand vs 3.763 parts per thousand,P < 0.001). Average age of NAFLD-CRC (58.79 +/- 12.353) or nonNAFLD-CRC (59.26 +/- 13.156) was significantly higher than NAFLD-nonCRC (54.15 +/- 14.167,p < 0.001). But age had no significant difference between NAFLD-CRC and nonNAFLD-CRC (P > 0.05). There was no different gender distribution for three groups (P > 0.05). NAFLD-CRC had lower anaemia-related routine clinical indicators such as decrease of red blood cell count, mean hemoglobin content and hemoglobin than NAFLD-nonCRC (P < 0.05 for all). Anemia of NAFLD-CRC was typical but it might be slighter than nonNAFLD-CRC. More interestingly, NAFLD-CRC had distinct characteristics of leukocyte system such as lower white blood cell count (WBC) and neutrophil count (NEU_C) and higher basophil percentage (BAS_Per) than nonNAFLD-CRC and NAFLD-nonCRC (P < 0.05 for all). Compared with NAFLD-nonCRC, the change of WBC, BAS_Per and NEU_C in NAFLD-CRC was different from that in nonNAFLD-CRC. In addition, NAFLD-CRC had a higher level of low density lipoprotein (LDL) and high density lipoprotein (HDL), lower level of triglyceride (TG) and Albumin-to-globulin ratio (A/G) than NFLD-nonCRC (P < 0.05 for all). Conclusions NAFLD is associated with a high incidence of CRC. Age is an important factor for CRC and the CRC incidence increases with age. Anemia-related blood routine clinical indicators, leukocyte system and blood lipid indicators may be more important variables for identifying CRC in NAFLD. So blood routine test and liver function/blood lipid test are valuable for screening CRC in NAFLD.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Hepatocellular carcinoma surveillance in nonalcoholic fatty liver disease patients
    Truong, Emily
    Noureddin, Mazen
    HEPATOMA RESEARCH, 2022, 8
  • [42] Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
    Chatrath, Hemant
    Vuppalanchi, Raj
    Chalasani, Naga
    SEMINARS IN LIVER DISEASE, 2012, 32 (01) : 22 - 29
  • [43] Cholecystectomy is associated with a lower risk of colorectal adenoma in patients with nonalcoholic fatty liver disease
    Song, Yang
    Hu, Doudou
    Cui, Xianghua
    Chu, Leilei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 183 - 183
  • [44] Nonalcoholic fatty liver disease and cardiovascular disease
    Liu, Hong
    Lu, Hong-Yun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (26) : 8407 - 8415
  • [45] Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension
    Zhao, Yan-Ci
    Zhao, Guo-Jun
    Chen, Ze
    She, Zhi-Gang
    Cai, Jingjing
    Li, Hongliang
    HYPERTENSION, 2020, 75 (02) : 275 - 284
  • [46] Serum uric acid and nonalcoholic fatty liver disease
    Fan, Jia
    Wang, Dongxu
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [47] Paediatric nonalcoholic fatty liver disease
    Alisi, Anna
    Carpino, Guido
    Nobili, Valerio
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (03) : 279 - 284
  • [48] Remnant cholesterol and severity of nonalcoholic fatty liver disease
    Huang, Hangkai
    Wang, Jinghua
    Wu, Li
    Ruan, Jiaqi
    Hou, Linxiao
    Shen, Chao
    Xu, Chengfu
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01)
  • [49] Nonalcoholic fatty liver disease and diabetes
    Bellini, Maria Irene
    Urciuoli, Irene
    Del Gaudio, Giovanni
    Polti, Giorgia
    Iannetti, Giovanni
    Gangitano, Elena
    Lori, Eleonora
    Lubrano, Carla
    Cantisani, Vito
    Sorrenti, Salvatore
    D'Andrea, Vito
    WORLD JOURNAL OF DIABETES, 2022, 13 (09) : 668 - 682
  • [50] Association of statins with nonalcoholic fatty liver disease in patients with diabetes
    Shah, Raj
    Kong, Alexander
    De Melo, Silvio
    Boktor, Moheb
    Henriquez, Richard
    Mandalia, Amar
    Samant, Hrishikesh
    Alvarez, Carlos A.
    Mansi, Ishak A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (06) : 497 - 510